MustGrow Biologics Corp.
MGRO.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.72% | -2,436.37% | -1,106.26% | -648.88% | -569.42% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.20% | 21.84% | 71.44% | 49.37% | 56.11% |
| Change in Net Operating Assets | 99.77% | 114.77% | -119.60% | -246.18% | 67.06% |
| Cash from Operations | -35.98% | -1,190.90% | -2,525.69% | -1,613.04% | -987.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 52.63% | 54.41% | 97.64% | -- | -- |
| Issuance of Common Stock | -- | -- | 37.16% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,900.85% | 1,902.61% | 1,902.00% | 2,174.23% | -347.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.78% | 59.54% | -701.89% | -1,400.22% | -1,549.76% |